Adam Dahlberg
Boardmember
Medical Science
Senzime
Sweden
Biography
Dahlberg, MBA from the Stockholm School of Economics, conducts venture capital activities, in-house and in the form of co-investment with other companies and individuals. Dahlberg has 15 years of experience investing in small technology-intensive firms to commercialize technological achievements. Past investments include Qlik Technologies Inc., PiezoMotor Uppsala AB and Corline Systems AB, a company engaged in, among other things biomedical engineering and regenerative medicine. Adam Dahlberg owned 2 968 573 shares in Senzime 17-06-30
Research Interest
His research interests lie in Healthcare and Medical Sciences. He is the Editor-in-Chief Member of many peer reviewed journals and his area of expertise credits him with many publications in national and international journals. He is committed to highest standards of excellence and it proves through his authorship of many books.
